{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:25:53Z","timestamp":1792099553423,"version":"4.4.0"},"reference-count":49,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"\n Importance<\/jats:title>\n Current pretransplant clinical scoring systems fail to accurately estimate post\u2013liver transplant (LT) survival, making recipient selection challenging. Persistent immune dysfunction contributes to early LT recipient mortality but is not captured by existing models.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To identify plasma biomarkers of pretransplant immune dysfunction and to develop a biomarker-based pre-LT risk stratification tool to predict post-LT mortality.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n Prospective biomarker analysis of consecutively enrolled adult LT recipients was conducted. Healthy controls were included for baseline comparison. Patients undergoing LT at Houston Methodist Hospital (October 1, 2013, to December 31, 2017) and Rutgers\/University Hospital (January 1, 2019, to March 31, 2021) were enrolled under an institutional review board\u2013approved protocol, and data were censored on March 31, 2023, and analyzed. Patients with cirrhosis older than 18 years undergoing deceased donor LT were included. Exclusion criteria were age greater than 70 years, cancer other than hepatocellular carcinoma, retransplant, status 1A, intraoperative mortality, multivisceral transplant (except liver-kidney), and sample availability.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Plasma cytokine, chemokine, and immune exhaustion biomarkers were quantified using multiplex Luminex assays at the time of transplant. Clinical, demographic, and laboratory data were extracted from institutional databases.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was all-cause mortality within 1 year of LT. Secondary outcomes included graft survival, infections, rejection, readmissions, and 24-month survival.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n A total of 779 adult LTs were performed between 2007 and 2017, with prospective biomarker analysis of 279 consecutively enrolled LT recipients between 2018 and 2022. Median (IQR) participant age was 56.7 (48.2-62.5) years, and 110 of 279 patients (39.4%) were female. Pre-LT plasma levels of B-cell activating factor, C-C motif chemokine ligand 1, eotaxin, fractalkine, interleukin 1\u03b2 (IL-1\u03b2), sIL-6R\u03b2, metalloproteinase (MMP) 2, and MMP3 were significantly associated with 1-year post-LT mortality. Multivariable Cox proportional hazards modeling identified fractalkine and MMP3 as independent predictors of early post-LT mortality. These were used to develop the Liver Immune Frailty Index (LIFI), stratifying patients into low, moderate, and high risk. One-year mortality was 1.9%, 10.3%, and 63.6% for LIFI-low, -moderate, and -high, respectively. Relative risk of death within 1 year was 5.43 (95% CI, 1.59-18.60;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001) for LIFI-moderate and 33.41 (95% CI, 11.48-97.25;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001) for LIFI-high compared to LIFI-low. LIFI demonstrated strong discrimination (C statistic, 0.83) and was associated with post-LT infections, longer hospital stays, and reduced patient survival.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n Per the results of this diagnostic\/prognostic study, LIFI identifies LT candidates with severe immune dysfunction at high risk for early post-LT mortality, offering a preoperative, objective tool to refine transplant candidacy, guide perioperative management, and improve LT outcomes.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamasurg.2025.6539","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T16:30:33Z","timestamp":1770827433000},"page":"339","source":"Crossref","is-referenced-by-count":4,"title":["Development and Internal Validation of a Pretransplant Biomarker Panel for Mortality Prediction Following Liver Transplant"],"prefix":"10.1001","volume":"161","author":[{"given":"Guergana G.","family":"Panayotova","sequence":"first","affiliation":[{"name":"Rutgers New Jersey Medical School, Newark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sopio","family":"Simonishvili","sequence":"additional","affiliation":[{"name":"Rutgers New Jersey Medical School, Newark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianhua","family":"Jin","sequence":"additional","affiliation":[{"name":"Rutgers New Jersey Medical School, Newark"},{"name":"Rutgers Health School of Graduate Studies, Newark, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duc T.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Graviss","sequence":"additional","affiliation":[{"name":"Houston Methodist Hospital, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Qin","sequence":"additional","affiliation":[{"name":"Rutgers New Jersey Medical School, Newark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Xynogala","sequence":"additional","affiliation":[{"name":"Rutgers New Jersey Medical School, Newark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tumininu","family":"Ayorinde","sequence":"additional","affiliation":[{"name":"Rutgers New Jersey Medical School, Newark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie J.","family":"Minze","sequence":"additional","affiliation":[{"name":"Houston Methodist Hospital, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Lemenze","sequence":"additional","affiliation":[{"name":"Rutgers Health School of Graduate Studies, Newark, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krupa R.","family":"Mysore","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Corkrean","sequence":"additional","affiliation":[{"name":"Houston Methodist Hospital, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda W.","family":"Moore","sequence":"additional","affiliation":[{"name":"Houston Methodist Hospital, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Paterno","sequence":"additional","affiliation":[{"name":"Rutgers New Jersey Medical School, Newark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Saharia","sequence":"additional","affiliation":[{"name":"Houston Methodist Hospital, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance M.","family":"Mobley","sequence":"additional","affiliation":[{"name":"Houston Methodist Hospital, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpit","family":"Amin","sequence":"additional","affiliation":[{"name":"Rutgers New Jersey Medical School, Newark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Hobeika","sequence":"additional","affiliation":[{"name":"Houston McGovern Medical School, University of Texas, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian C.","family":"Li","sequence":"additional","affiliation":[{"name":"Houston Methodist Hospital, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Gaglio","sequence":"additional","affiliation":[{"name":"Rutgers New Jersey Medical School, Newark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Mark","family":"Ghobrial","sequence":"additional","affiliation":[{"name":"Houston Methodist Hospital, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James V.","family":"Guarrera","sequence":"additional","affiliation":[{"name":"Rutgers New Jersey Medical School, Newark"},{"name":"Thomas Jefferson University Sidney Kimmel Medical College, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keri E.","family":"Lunsford","sequence":"additional","affiliation":[{"name":"Rutgers New Jersey Medical School, Newark"},{"name":"Rutgers Health School of Graduate Studies, Newark, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"soi250099r1","doi-asserted-by":"publisher","first-page":"k2817","DOI":"10.1136\/bmj.k2817","article-title":"Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study.","volume":"362","author":"Tapper","year":"2018","journal-title":"BMJ"},{"issue":"1","key":"soi250099r3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1053\/gast.2003.50016","article-title":"Model for end-stage liver disease (MELD) and allocation of donor livers.","volume":"124","author":"Wiesner","year":"2003","journal-title":"Gastroenterology"},{"issue":"2","key":"soi250099r4","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease.","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"issue":"3","key":"soi250099r5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jvir.2022.12.029","article-title":"Updates on the Model for End-Stage Liver Disease score and impact on the liver transplant waiting list: a narrative review.","volume":"34","author":"Bayona Molano","year":"2023","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"soi250099r6","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/hep.30624","article-title":"Patients with acute on chronic liver failure grade 3 have greater 14-day waitlist mortality than status-1a patients.","volume":"70","author":"Sundaram","year":"2019","journal-title":"Hepatology"},{"issue":"3","key":"soi250099r7","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15644","article-title":"Mechanisms of immunity in acutely decompensated cirrhosis and acute-on-chronic liver failure.","volume":"45","author":"Engelmann","year":"2025","journal-title":"Liver Int"},{"issue":"7","key":"soi250099r8","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/lt.20169","article-title":"Pretransplant MELD score and post liver transplantation survival in the UK and Ireland.","volume":"10","author":"Jacob","year":"2004","journal-title":"Liver Transpl"},{"issue":"1","key":"soi250099r9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/01.TP.0000101009.91516.FC","article-title":"Predicting outcome after liver transplantation: utility of the Model for End-Stage Liver Disease and a newly derived discrimination function.","volume":"77","author":"Desai","year":"2004","journal-title":"Transplantation"},{"issue":"2","key":"soi250099r10","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1600-6143.2008.02491.x","article-title":"D-MELD, a simple predictor of post liver transplant mortality for optimization of donor\/recipient matching.","volume":"9","author":"Halldorson","year":"2009","journal-title":"Am J Transplant"},{"issue":"5","key":"soi250099r11","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/SLA.0b013e3182365081","article-title":"Are there better guidelines for allocation in liver transplantation? a novel score targeting justice and utility in the Model for End-Stage Liver Disease era.","volume":"254","author":"Dutkowski","year":"2011","journal-title":"Ann Surg"},{"issue":"12","key":"soi250099r12","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1111\/j.1600-6143.2008.02400.x","article-title":"Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation.","volume":"8","author":"Rana","year":"2008","journal-title":"Am J Transplant"},{"issue":"6","key":"soi250099r13","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1097\/SLA.0000000000000265","article-title":"Liver transplantation in highest acuity recipients: identifying factors to avoid futility.","volume":"259","author":"Petrowsky","year":"2014","journal-title":"Ann Surg"},{"issue":"5","key":"soi250099r14","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/SLA.0000000000001887","article-title":"Risk Avoidance and liver transplantation: a single-center experience in a national network.","volume":"264","author":"Ravaioli","year":"2016","journal-title":"Ann Surg"},{"issue":"25","key":"soi250099r15","doi-asserted-by":"publisher","first-page":"8061","DOI":"10.3748\/wjg.v20.i25.8061","article-title":"Clinical relevance of sarcopenia in patients with cirrhosis.","volume":"20","author":"Montano-Loza","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"4","key":"soi250099r16","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.bpg.2013.06.018","article-title":"Liver disease and malnutrition.","volume":"27","author":"Purnak","year":"2013","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"soi250099r17","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jss.2021.09.030","article-title":"Perioperative skeletal muscle fluctuations in high-acuity liver transplantation.","volume":"270","author":"Chong","year":"2022","journal-title":"J Surg Res"},{"issue":"12","key":"soi250099r18","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1097\/TP.0000000000001433","article-title":"Performance-based measures associate with frailty in patients with end-stage liver disease.","volume":"100","author":"Lai","year":"2016","journal-title":"Transplantation"},{"issue":"5","key":"soi250099r19","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/MOT.0000000000000911","article-title":"Clinical and biomarker assessment of frailty in liver transplantation.","volume":"26","author":"Ayorinde","year":"2021","journal-title":"Curr Opin Organ Transplant"},{"issue":"4","key":"soi250099r20","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jhep.2017.11.030","article-title":"A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: a competing risk analysis in a national cohort.","volume":"68","author":"van Vugt","year":"2018","journal-title":"J Hepatol"},{"issue":"3","key":"soi250099r21","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1086\/509580","article-title":"The impact of cirrhosis on CD4+ T cell counts in HIV-seronegative patients.","volume":"44","author":"McGovern","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"1","key":"soi250099r22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1046\/j.1365-2249.1997.d01-985.x","article-title":"Analysis of T cell activation pathways in patients with liver cirrhosis, impaired delayed hypersensitivity and other T cell-dependent functions.","volume":"108","author":"Schirren","year":"1997","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"soi250099r23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41575-021-00520-7","article-title":"Cirrhosis-associated immune dysfunction.","volume":"19","author":"Albillos","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"soi250099r24","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7537649","article-title":"Immune dysfunction and albumin-related immunity in liver cirrhosis.","volume":"2019","author":"Wilde","year":"2019","journal-title":"Mediators Inflamm"},{"issue":"3","key":"soi250099r26","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1053\/j.gastro.2014.11.041","article-title":"Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitis.","volume":"148","author":"Markwick","year":"2015","journal-title":"Gastroenterology"},{"key":"soi250099r27","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ebiom.2019.10.011","article-title":"CD8+T cells from patients with cirrhosis display a phenotype that may contribute to cirrhosis-associated immune dysfunction.","volume":"49","author":"Leboss\u00e9","year":"2019","journal-title":"EBioMedicine"},{"issue":"2","key":"soi250099r28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/ajt.14546","article-title":"Longitudinal assessment of T cell inhibitory receptors in liver transplant recipients and their association with posttransplant infections.","volume":"18","author":"Mysore","year":"2018","journal-title":"Am J Transplant"},{"issue":"8195 pt 1","key":"soi250099r29","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0140-6736(80)90284-6","article-title":"Malnutrition and immuno-incompetence in patients with liver disease.","volume":"2","author":"O\u2019Keefe","year":"1980","journal-title":"Lancet"},{"issue":"3","key":"soi250099r30","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1080\/21505594.2016.1139279","article-title":"Bloodstream infections after solid-organ transplantation.","volume":"7","author":"Kritikos","year":"2016","journal-title":"Virulence"},{"issue":"4","key":"soi250099r31","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1111\/ajt.14065","article-title":"Risk assessment in high- and low-MELD liver transplantation.","volume":"17","author":"Schlegel","year":"2017","journal-title":"Am J Transplant"},{"issue":"3","key":"soi250099r32","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1161\/ATVBAHA.111.237412","article-title":"Fractalkine: a survivor\u2019s guide: chemokines as antiapoptotic mediators.","volume":"32","author":"White","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"soi250099r33","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s13054-015-1125-0","article-title":"Plasma fractalkine is a sustained marker of disease severity and outcome in sepsis patients.","volume":"19","author":"Hoogendijk","year":"2015","journal-title":"Crit Care"},{"key":"soi250099r34","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104569","article-title":"Role of fractalkine in promoting inflammation in sepsis-induced multiple organ dysfunction.","volume":"85","author":"Chen","year":"2020","journal-title":"Infect Genet Evol"},{"issue":"2","key":"soi250099r35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.yexmp.2007.04.003","article-title":"Matrix metalloproteinase-3 (stromelysin-1) in acute inflammatory tissue injury.","volume":"83","author":"Nerusu","year":"2007","journal-title":"Exp Mol Pathol"},{"issue":"8","key":"soi250099r36","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nri1418","article-title":"Matrix metalloproteinases as modulators of inflammation and innate immunity.","volume":"4","author":"Parks","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"soi250099r37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084748","article-title":"Matrix metalloproteinase 3 promotes cellular anti-dengue virus response via interaction with transcription factor NF?B in cell nucleus.","volume":"9","author":"Zuo","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"soi250099r38","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.2353\/ajpath.2006.060005","article-title":"Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis.","volume":"169","author":"Si-Tayeb","year":"2006","journal-title":"Am J Pathol"},{"issue":"8","key":"soi250099r39","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.4049\/jimmunol.173.8.5171","article-title":"Impaired immunity to intestinal bacterial infection in stromelysin-1 (matrix metalloproteinase-3)-deficient mice.","volume":"173","author":"Li","year":"2004","journal-title":"J Immunol"},{"key":"soi250099r40","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.1038\/srep05002","article-title":"Role of plasma matrix-metalloproteases (MMPs) and their polymorphisms (SNPs) in sepsis development and outcome in ICU patients.","volume":"4","author":"Martin","year":"2014","journal-title":"Sci Rep"},{"issue":"2","key":"soi250099r41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.31053\/1853.0605.v74.n2.14608","article-title":"IL-6, MMP 3 and prognosis in previously healthy sepsis patients.","volume":"74","author":"Ricarte-Bratti","year":"2017","journal-title":"Rev Fac Cien Med Univ Nac Cordoba"},{"issue":"1","key":"soi250099r42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/SHK.0000000000001833","article-title":"Elevated plasma levels of matrix metalloproteinase-3 and tissue-inhibitor of matrix metalloproteinases-1 associate with organ dysfunction and mortality in sepsis.","volume":"57","author":"Jones","year":"2022","journal-title":"Shock"},{"issue":"3","key":"soi250099r43","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2024.100599","article-title":"Dynamic immune recovery process after liver transplantation revealed by single-cell multi-omics analysis.","volume":"5","author":"Wang","year":"2024","journal-title":"Innovation (Camb)"},{"issue":"12","key":"soi250099r44","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/s41575-024-00974-5","article-title":"Hepatic immune regulation and sex disparities.","volume":"21","author":"Burra","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"soi250099r45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100870","article-title":"Sex differences in chronic liver disease and benign liver lesions.","volume":"5","author":"Cooper","year":"2023","journal-title":"JHEP Rep"},{"issue":"7","key":"soi250099r46","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.tips.2024.05.004","article-title":"Implications of innate immune sexual dimorphism for MASLD pathogenesis and treatment.","volume":"45","author":"Booijink","year":"2024","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"soi250099r47","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1016\/j.jhep.2023.08.013","article-title":"Sex differences in prevalence and prognosis of steatotic liver disease phenotypes: biological sex matters.","volume":"80","author":"Ji","year":"2024","journal-title":"J Hepatol"},{"issue":"1","key":"soi250099r48","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41392-023-01451-2","article-title":"Immunosenescence: molecular mechanisms and diseases.","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"soi250099r49","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2217\/ahe.09.31","article-title":"Bone marrow, thymus and blood: changes across the lifespan.","volume":"5","year":"2009","journal-title":"Aging health"},{"key":"soi250099r2"},{"key":"soi250099r25","unstructured":"Peripheral blood mononuclear cells (PBMC) and associated plasma collection. US National Institute of Allergy and Infectious Diseases. Accessed October 4, 2022. https:\/\/www.niaid.nih.gov\/sites\/default\/files\/PBMC_SOP.pdf"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2844832\/jamasurgery_panayotova_2026_oi_250099_1773954900.3784.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T15:00:47Z","timestamp":1775660447000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2844832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2025.6539","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,1]]}}}